Adherence Study in COPD Patients
Public ClinicalTrials.gov record NCT02864342. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized Clinical Study to Assess the Impact of Symbicort® pMDI Medication Reminders on Adherence in COPD Patients
Study identification
- NCT ID
- NCT02864342
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- AstraZeneca
- Industry
- Enrollment
- 138 participants
Conditions and interventions
Conditions
Interventions
- Arm 1: BreatheMate device with application Device
- Arm 2: BreatheMate device without application Device
Device
Eligibility (public fields only)
- Age range
- 40 Years to 130 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Aug 11, 2016
- Primary completion
- Oct 30, 2017
- Completion
- Oct 30, 2017
- Last update posted
- Nov 19, 2018
2016 – 2017
United States locations
- U.S. sites
- 8
- U.S. states
- 6
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Clearwater | Florida | 37765 | — |
| Research Site | Tampa | Florida | 33603 | — |
| Research Site | Marlton | New Jersey | 08053 | — |
| Research Site | Brooklyn | New York | 11229 | — |
| Research Site | Charlotte | North Carolina | 28207 | — |
| Research Site | Downingtown | Pennsylvania | 19335 | — |
| Research Site | Philadelphia | Pennsylvania | 19140 | — |
| Research Site | Spartanburg | South Carolina | 29303 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02864342, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 19, 2018 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02864342 live on ClinicalTrials.gov.